Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

The FDA clearance for the Zio AT device upgrades signals the potential for further innovation and stock growth.

The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac ...

Chicago-based Cardiosense has received 510(k) clearance from the FDA for its CardioTag device, a multimodal wearable sensor.  The CardioTag is designed to provide clinicians with a comprehensive, ...

Enlil, Inc., a Shifamed Portfolio Company and leader in enabling MedTech product innovation, today announced seven new strategic partnerships formed to date in 2025. These agreements, spanning ...

Congress and the FDA are pushing pharmaceutical companies to replace animals with technology for drug research. That’s a long ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for CardioTag, Cardiosense’s multimodal, wearable ...

Cardiosense has received U.S. Food & Drug Administration clearance for a wearable sensor that can measure multiple cardiac ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.

PainChek, EMVision and Clever Culture Systems are among ASX health companies reporting quarterly results today.